ArticleEcancermedicalscience2025

Evaluating Ki-67 and PR as prognostic indicators in CDK4/6 inhibitor treatment for metastatic breast cancer.

María Florencia Illia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.